These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1388 related items for PubMed ID: 8895761
1. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA. Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761 [Abstract] [Full Text] [Related]
2. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Simoneau M, Aboulkassim TO, LaRue H, Rousseau F, Fradet Y. Oncogene; 1999 Jan 07; 18(1):157-63. PubMed ID: 9926930 [Abstract] [Full Text] [Related]
3. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Keen AJ, Knowles MA. Oncogene; 1994 Jul 07; 9(7):2083-8. PubMed ID: 8208555 [Abstract] [Full Text] [Related]
4. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Habuchi T, Devlin J, Elder PA, Knowles MA. Oncogene; 1995 Oct 19; 11(8):1671-4. PubMed ID: 7478593 [Abstract] [Full Text] [Related]
5. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. van Tilborg AA, Groenfeld LE, van der Kwast TH, Zwarthoff EC. Br J Cancer; 1999 May 19; 80(3-4):489-94. PubMed ID: 10408858 [Abstract] [Full Text] [Related]
6. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D. Cancer Res; 2003 Nov 15; 63(22):7652-6. PubMed ID: 14633685 [Abstract] [Full Text] [Related]
7. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK. Cancer Res; 1995 May 15; 55(10):2150-7. PubMed ID: 7743516 [Abstract] [Full Text] [Related]
8. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Pollock PM, Welch J, Hayward NK. Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846 [Abstract] [Full Text] [Related]
9. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Genes Chromosomes Cancer; 1999 Oct 01; 26(2):171-5. PubMed ID: 10469456 [Abstract] [Full Text] [Related]
10. Role of chromosome 9 in human bladder cancer. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Cancer Res; 1993 Sep 01; 53(17):4066-70. PubMed ID: 8358736 [Abstract] [Full Text] [Related]
11. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Cancer Res; 1994 Jun 01; 54(11):2848-51. PubMed ID: 8187066 [Abstract] [Full Text] [Related]
12. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Cairns P, Shaw ME, Knowles MA. Oncogene; 1993 Apr 01; 8(4):1083-5. PubMed ID: 8096074 [Abstract] [Full Text] [Related]
13. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW. Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029 [Abstract] [Full Text] [Related]
14. Evidence for two bladder cancer suppressor loci on human chromosome 9. Ruppert JM, Tokino K, Sidransky D. Cancer Res; 1993 Nov 01; 53(21):5093-5. PubMed ID: 8221642 [Abstract] [Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
16. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J. Cancer Res; 1997 Mar 01; 57(5):907-12. PubMed ID: 9041193 [Abstract] [Full Text] [Related]
17. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Merlo A, Gabrielson E, Askin F, Sidransky D. Cancer Res; 1994 Feb 01; 54(3):640-2. PubMed ID: 8306323 [Abstract] [Full Text] [Related]
18. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F. Cancer Res; 1999 Sep 15; 59(18):4662-7. PubMed ID: 10493522 [Abstract] [Full Text] [Related]
19. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS, Clayton RN. Cancer Res; 1997 Jul 01; 57(13):2703-9. PubMed ID: 9205080 [Abstract] [Full Text] [Related]
20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD. Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]